Nasdaq · Healthcare

ORTHOPEDIATRICS CORP (KIDS)

As-reported financials and recent SEC filings for ORTHOPEDIATRICS CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$236.3M

Net income

$-39.6M

Net margin

-16.8%

Diluted EPS

$-1.69

ROE

-11.4%

P/E (TTM)

—

Market cap

$521.4M

Debt / equity

0.3×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$236.3M	$204.7M	$148.7M	$122.3M	$98.0M
Gross profit	$172.7M	$148.6M	$111.3M	$90.7M	$73.4M
Operating income	$-39.2M	$-35.0M	$-26.8M	$-25.4M	$-18.0M
Net income	$-39.6M	$-37.8M	$-21.0M	$1.3M	$-16.3M
Diluted EPS	$-1.69	$-1.64	$-0.92	$0.06	$-0.84

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-06-10

42026-06-10

42026-06-10

42026-06-10

42026-06-10

42026-06-10

42026-06-10

42026-06-10

Go deeper on KIDS

Search ORTHOPEDIATRICS CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.